This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Brugada Ablation of VF Substrate Ongoing MultiCenter Registry

Sponsored by Pacific Rim Electrophysiology Research Institute

About this trial

Last updated 2 years ago

Study ID

BRAVO Registry

Status

Completed

Type

Observational

Placebo

No

Accepting

18-75 Years
18 to 80 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 3 years ago

What is this trial about?

Current treatment of high-risk Brugada Syndrome (BrS) patients (pts) with recurrent VF is limited. Catheter ablation (CA) has been performed for BrS but a large study with long-term outcomes of CA in BrS ablation are lacking.

What are the participation requirements?

Yes

Inclusion Criteria

- Symptomatic Brugada Syndrome patients who had undergone catheter ablation of the arrhythmogenic substrates.

No

Exclusion Criteria

- Patients who will not commit to regular follow up.

Locations

Location

Status